112 related articles for article (PubMed ID: 15467745)
1. The small G-protein RalA stimulates metastasis of transformed cells.
Tchevkina E; Agapova L; Dyakova N; Martinjuk A; Komelkov A; Tatosyan A
Oncogene; 2005 Jan; 24(3):329-35. PubMed ID: 15467745
[TBL] [Abstract][Full Text] [Related]
2. RalA requirement for v-Src- and v-Ras-induced tumorigenicity and overproduction of urokinase-type plasminogen activator: involvement of metalloproteases.
Aguirre-Ghiso JA; Frankel P; Farias EF; Lu Z; Jiang H; Olsen A; Feig LA; de Kier Joffe EB; Foster DA
Oncogene; 1999 Aug; 18(33):4718-25. PubMed ID: 10467419
[TBL] [Abstract][Full Text] [Related]
3. Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.
Lim KH; O'Hayer K; Adam SJ; Kendall SD; Campbell PM; Der CJ; Counter CM
Curr Biol; 2006 Dec; 16(24):2385-94. PubMed ID: 17174914
[TBL] [Abstract][Full Text] [Related]
4. RalA mediates v-Src, v-Ras, and v-Raf regulation of CD44 and fibronectin expression in NIH3T3 fibroblasts.
Ladeda V; Frankel P; Feig LA; Foster DA; Bal de Kier Joffe E; Aguirre-Ghiso JA
Biochem Biophys Res Commun; 2001 May; 283(4):854-61. PubMed ID: 11350063
[TBL] [Abstract][Full Text] [Related]
5. The role of Ral A in epidermal growth factor receptor-regulated cell motility.
Gildea JJ; Harding MA; Seraj MJ; Gulding KM; Theodorescu D
Cancer Res; 2002 Feb; 62(4):982-5. PubMed ID: 11861368
[TBL] [Abstract][Full Text] [Related]
6. Activated ras regulates the proliferation/apoptosis balance and early survival of developing micrometastases.
Varghese HJ; Davidson MT; MacDonald IC; Wilson SM; Nadkarni KV; Groom AC; Chambers AF
Cancer Res; 2002 Feb; 62(3):887-91. PubMed ID: 11830548
[TBL] [Abstract][Full Text] [Related]
7. RalGDS is required for tumor formation in a model of skin carcinogenesis.
González-García A; Pritchard CA; Paterson HF; Mavria G; Stamp G; Marshall CJ
Cancer Cell; 2005 Mar; 7(3):219-26. PubMed ID: 15766660
[TBL] [Abstract][Full Text] [Related]
8. RalA regulates vascular endothelial growth factor-C (VEGF-C) synthesis in prostate cancer cells during androgen ablation.
Rinaldo F; Li J; Wang E; Muders M; Datta K
Oncogene; 2007 Mar; 26(12):1731-8. PubMed ID: 16964283
[TBL] [Abstract][Full Text] [Related]
9. [The rate of in vivo selection of highly metastatic and resistance-inhibiting variants of tumor cells].
Vendrov EL; Deĭchman GI
Biull Eksp Biol Med; 1986 May; 101(5):607-10. PubMed ID: 3708148
[TBL] [Abstract][Full Text] [Related]
10. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ
Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435
[TBL] [Abstract][Full Text] [Related]
11. Ras effector pathways modulate scatter factor-stimulated NF-kappaB signaling and protection against DNA damage.
Fan S; Meng Q; Laterra JJ; Rosen EM
Oncogene; 2007 Jul; 26(33):4774-96. PubMed ID: 17297451
[TBL] [Abstract][Full Text] [Related]
12. Karyotypic analysis of diploid or near diploid metastatic Harvey ras transformed rat embryo fibroblasts.
Muschel RJ; Nakahara K; Chu E; Pozzatti R; Liotta LA
Cancer Res; 1986 Aug; 46(8):4104-8. PubMed ID: 3731077
[TBL] [Abstract][Full Text] [Related]
13. Ral: mediator of membrane trafficking.
van Dam EM; Robinson PJ
Int J Biochem Cell Biol; 2006; 38(11):1841-7. PubMed ID: 16781882
[TBL] [Abstract][Full Text] [Related]
14. Activation of RalA is critical for Ras-induced tumorigenesis of human cells.
Lim KH; Baines AT; Fiordalisi JJ; Shipitsin M; Feig LA; Cox AD; Der CJ; Counter CM
Cancer Cell; 2005 Jun; 7(6):533-45. PubMed ID: 15950903
[TBL] [Abstract][Full Text] [Related]
15. Ral GTPases: corrupting the exocyst in cancer cells.
Camonis JH; White MA
Trends Cell Biol; 2005 Jun; 15(6):327-32. PubMed ID: 15953551
[TBL] [Abstract][Full Text] [Related]
16. Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model.
Rybko VA; Knizhnik AV; Komelkov AV; Aushev VN; Trukhanova LS; Tchevkina EM
Cancer Cell Int; 2011 Jun; 11(1):22. PubMed ID: 21714887
[TBL] [Abstract][Full Text] [Related]
17. Elevated phospholipase D activity in H-Ras- but not K-Ras-transformed cells by the synergistic action of RalA and ARF6.
Xu L; Frankel P; Jackson D; Rotunda T; Boshans RL; D'Souza-Schorey C; Foster DA
Mol Cell Biol; 2003 Jan; 23(2):645-54. PubMed ID: 12509462
[TBL] [Abstract][Full Text] [Related]
18. [Resistance-suppressing activity of transformed Syrian hamster cells and their ability to metastasize].
Deĭchman GI; Kliuchareva TE; Kashkina LM; Matveeva VA; Teplova MA
Biull Eksp Biol Med; 1981 Nov; 92(11):596-9. PubMed ID: 7317641
[TBL] [Abstract][Full Text] [Related]
19. High expression of shMDG1 gene is associated with low metastatic potential of tumor cells.
Isachenko N; Dyakova N; Aushev V; Chepurnych T; Gurova K; Tatosyan A
Oncogene; 2006 Jan; 25(2):317-22. PubMed ID: 16205647
[TBL] [Abstract][Full Text] [Related]
20. Decreased tumorigenicity of c-Myc-transformed fibroblasts expressing active USF2.
Choe C; Chen N; Sawadogo M
Exp Cell Res; 2005 Jan; 302(1):1-10. PubMed ID: 15541720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
